Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma

Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma

The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) underscores the need for better understanding of its complex pathogenesis. Lipid accumulation in hepatocytes is among principal mechanisms contributing to MASLD development. While routine lipid parameters a...

Full description

Bibliographic Details
Main Authors: Irena Frankovic, Ivana Djuricic, Ana Ninic, Jelena Vekic, Tara Vorkapic, Sanja Erceg, Tamara Gojkovic, Ratko Tomasevic, Milica Mamic, Milos Mitrovic, Aleksandra Zeljkovic
Format: Article
Language:English
Published: MDPI AG 2024-07-01
Series:Biomolecules
Subjects:
MASLD
plasma fatty acids
n-6 PUFAs
n-3 PUFAs
linoleic acid
Online Access:https://www.mdpi.com/2218-273X/14/8/902

Internet

https://www.mdpi.com/2218-273X/14/8/902

Similar Items